Purple Biotech Analyst Ratings
Purple Biotech Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/21/2023 | 566.67% | JonesTrading | → $8 | Initiates Coverage On | → Buy |
| 05/17/2023 | 483.33% | HC Wainwright & Co. | → $7 | Reiterates | Buy → Buy |
| 05/17/2023 | 816.67% | Chardan Capital | → $11 | Reiterates | Buy → Buy |
| 02/09/2023 | 483.33% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/09/2023 | 816.67% | Chardan Capital | → $11 | Reiterates | → Buy |
| 10/17/2022 | 483.33% | HC Wainwright & Co. | → $7 | Initiates Coverage On | → Buy |
| 09/08/2022 | 816.67% | Chardan Capital | → $11 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 07/21/2023 | 566.67% | JonesTrading | → 8 美元 | 启动覆盖开启 | → 购买 |
| 05/17/2023 | 483.33% | HC Wainwright & Co. | → 7 美元 | 重申 | 购买 → 购买 |
| 05/17/2023 | 816.67% | 查丹资本 | → 11 美元 | 重申 | 购买 → 购买 |
| 02/09/2023 | 483.33% | HC Wainwright & Co. | → 7 美元 | 重申 | → 购买 |
| 02/09/2023 | 816.67% | 查丹资本 | → 11 美元 | 重申 | → 购买 |
| 2022 年 10 月 17 日 | 483.33% | HC Wainwright & Co. | → 7 美元 | 启动覆盖开启 | → 购买 |
| 09/08/2022 | 816.67% | 查丹资本 | → 11 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Purple Biotech (PPBT)?
紫色生物科技（PPBT）的目标价格是多少？
The latest price target for Purple Biotech (NASDAQ: PPBT) was reported by JonesTrading on July 21, 2023. The analyst firm set a price target for $8.00 expecting PPBT to rise to within 12 months (a possible 566.67% upside). 7 analyst firms have reported ratings in the last year.
JoneStrading于2023年7月21日公布了紫色生物科技（纳斯达克股票代码：PPBT）的最新目标股价。这家分析公司将目标股价定为8.00美元，预计PPBT将在12个月内升至12个月内（可能上涨566.67％）。去年有7家分析公司公布了评级。
What is the most recent analyst rating for Purple Biotech (PPBT)?
紫色生物科技（PPBT）的最新分析师评级是多少？
The latest analyst rating for Purple Biotech (NASDAQ: PPBT) was provided by JonesTrading, and Purple Biotech initiated their buy rating.
紫色生物科技（纳斯达克股票代码：PPBT）的最新分析师评级由JoneStrading提供，Purple Biotech启动了买入评级。
When is the next analyst rating going to be posted or updated for Purple Biotech (PPBT)?
Purple Biotech（PPBT）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Purple Biotech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Purple Biotech was filed on July 21, 2023 so you should expect the next rating to be made available sometime around July 21, 2024.
分析师在进行了广泛的研究（包括浏览公开财务报表、与Purple Biotech的高管和客户交谈以及听取财报电话会议）后得出了股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Purple Biotech的最后一次评级是在2023年7月21日提交的，因此您应该预计下一个评级将在2024年7月21日左右公布。
Is the Analyst Rating Purple Biotech (PPBT) correct?
分析师对 Purple Biotech (PPBT) 的评级是否正确？
While ratings are subjective and will change, the latest Purple Biotech (PPBT) rating was a initiated with a price target of $0.00 to $8.00. The current price Purple Biotech (PPBT) is trading at is $1.20, which is within the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的Purple Biotech（PPBT）评级是最初的，目标股价为0.00美元至8.00美元。Purple Biotech（PPBT）目前的交易价格为1.20美元，在分析师的预测区间内。